Skip to main content
Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.070
+0.010 (0.94%)
At close: Nov 22, 2024, 4:00 PM
1.100
+0.030 (2.80%)
After-hours: Nov 22, 2024, 7:48 PM EST

Heron Therapeutics Revenue

Heron Therapeutics had revenue of $32.81M in the quarter ending September 30, 2024, with 4.38% growth. This brings the company's revenue in the last twelve months to $137.74M, up 12.13% year-over-year. In the year 2023, Heron Therapeutics had annual revenue of $127.04M with 17.99% growth.

Revenue (ttm)
$137.74M
Revenue Growth
+12.13%
P/S Ratio
1.18
Revenue / Employee
$1,093,151
Employees
126
Market Cap
162.74M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023127.04M19.37M17.99%
Dec 31, 2022107.67M21.33M24.70%
Dec 31, 202186.35M-2.29M-2.59%
Dec 31, 202088.64M-57.33M-39.28%
Dec 31, 2019145.97M68.49M88.41%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nevro 419.15M
Adaptimmune Therapeutics 175.04M
Organigram Holdings 110.30M
Fulcrum Therapeutics 80.87M
2seventy bio 45.62M
Elutia 24.78M
Revenue Rankings

HRTX News

More News